For the Inventor, By the Inventor

Enter assignee name

Heidelberg, Germany

Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh

USPTO Granted Patents = 24

CIPO Patents = 1

EPO Patents = 12

Forward Citations = 83

Loading Chart...

Loading Chart...

32 inventors (with patents filed for the assignee):

Jens Pohl (13 out of 23 patents)

Rolf Bechtold (7 out of 15 patents)

Helge Neidhardt (7 out of 11 patents)

4. Michael Paulista (7 out of 11 patents)

5. Frank Ploeger (4 out of 4 patents)

6. Michael Kruse (4 out of 5 patents)

7. Gertrud Hötten (4 out of 8 patents)

8. Michio Kimura (3 out of 6 patents)

9. Mieko Katsuura (3 out of 6 patents)

10. Shinji Kawai (2 out of 6 patents)

11. Dirk Grafahrend (2 out of 4 patents)

12. Daniel Neumüller (2 out of 3 patents)

13. Denis Reibel (2 out of 8 patents)

14. Frank Plöger (2 out of 4 patents)

15. Yoshifumi Muraki (2 out of 2 patents)

24 patents: Sort by Forward Citations

1. 9782511 - Bioresorbable wound dressing (2017-10-10),

2. 9480649 - Lipid microparticle growth factor formulations (2016-11-01),

3. 9278156 - Bioresorbable wound dressing (2016-03-08),

4. 9200048 - High activity growth factor mutants (2015-12-01),

5. 8871710 - Method for inducing tissue growth, differentiation and/or regeneration by delivering a GDF-5 related precursor protein (2014-10-28),

6. 8361745 - Human growth and differentiation factor GDF-5 (2013-01-29),

7. 8188226 - High activity growth factor mutants (2012-05-29),

8. 8187837 - Optimized purification process of recombinant growth factor protein (2012-05-29),

9. 8163694 - Method of treating diseases or abnormal conditions of periodontal or dental tissues with GDF5 (2012-04-24),

10. 7642237 - Growth/differentiation factor of the TGF-β family (2010-01-05),

11. 7638129 - Monomer protein with bone morphogenetic activity and medicinal agent containing the same for preventing and treating diseases of cartilage and bone (2009-12-29),

12. 7485617 - Osteoinductive materials (2009-02-03),

13. 7365051 - Compounds with improved cartilage-inducing and/or bone-inducing activity (2008-04-29),

14. 7238657 - Cartilage/Bone inducing materials for preparation (2007-07-03),

15. 7235241 - Monomer protein with bone morphogenetic activity and medicinal agent containing the same for preventing and treating diseases of cartilage and bone (2007-06-26),

Biopharm Gesellschaft Zur Biotechnologischen Entwicklung von Pharmaka MBH is a leading biotechnology company focused on the research, development, and production of innovative pharmaceuticals. With a team of highly skilled scientists and state-of-the-art infrastructure, we strive to discover new drug candidates and bring them to the market. Our portfolio includes a wide range of therapeutics addressing various diseases such as cancer, autoimmune disorders, and infectious diseases. Visit our website to learn more about our cutting-edge research and groundbreaking discoveries.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

24 Patents

#13 in Heidelberg

#1,929 in Germany

#25,825 in the World

Heidelberg, Germany

Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh

Forward Citations = 83

32 inventors:

Jens Pohl (13 out of 23 patents)

Rolf Bechtold (7 out of 15 patents)

Helge Neidhardt (7 out of 11 patents)

4. Michael Paulista (7 out of 11 patents)

5. Frank Ploeger (4 out of 4 patents)

Please report any incorrect information to support@idiyas.com

Loading…